Tizanidine Hydrochloride
Product Images NDC 45865-954

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 45865-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (954)

Label for Tizanidine Hydrochloride Capsules 6 mg by medsource pharmaceuticals. The label indicates the product is generic for Zanaflex and shows dosage form as capsules. It includes warning text about dizziness or drowsiness and instructions to take tablet(s) daily. The package count is 30 capsules, with lot number and expiration date fields, and manufacturing information listing Apotex Inc., Toronto, Canada.*

FDA Label Image

Chemicalstructure (Chemical Structure)

Chemical structure of Tizanidine Hydrochloride, showing its molecular composition with chlorine, nitrogen, sulfur atoms, and the hydrochloride salt form.*

FDA Label Image

Figure2 (Figure 2)

A line graph showing improvement in Ashworth Score over 6 hours post-dose. It compares three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis measures improvement, while the x-axis tracks time in hours. Data points include error bars for variability.*

FDA Label Image

Figure3 (Figure 3)

A line graph showing the improvement in Ashworth Score over time for Tizanidine (mean dose 28.8 mg) compared to placebo. The graph plots data points and error bars at End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward), illustrating greater improvement with tizanidine at all points.*

FDA Label Image

Figure1 (Figure1)

A line graph showing plasma tizanidine concentration (ng/mL) over 24 hours post-dosing. The graph compares four conditions: 4 mg tizanidine tablets with food, tablets without food, capsules with food, and capsules without food, illustrating absorption and concentration changes over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.